Cardiovascular Medical Devices Market and Forecasts 2016-2026

LONDON, October 4, 2016 /PRNewswire/ --

Analysing Cardiac Rhythm Management, Prosthetics, Interventional Cardiology, Heart Monitoring and Diagnostics, also Assessing Pacemakers, Defibrillators, Ventricular Assist Products, Stents, Artificial Heart Valves, Catheters, Angioplasty Balloons, Guidewires, Electrocardiography, Cardio Output Monitoring and Accessories, Covering the US, Japan, China, India, Brazil, Russia and Europe (EU5)

Cardiovascular Medical Devices - How to Discover That Technology's Rising Commercial Potential
What is the future of devices for the human circulatory system? In visiongain's updated study you discover technological and commercial predictions from 2016. See what is possible.

That way you stay ahead for data, benefiting your work and authority. For those medical devices you explore sales results, developments, opportunities and revenue forecasts to 2026. Succeed through discovering companies' trends, progress and potential gains.

Forecasts and other analysis showing potential revenues from those cardio products
Discover how to help your reputation for commercial insight. Our study's purpose is showing you cardiovascular device revenues to 2026 at overall world, submarket and national level.

That way you reduce struggles to find information on devices for controlling and monitoring blood circulation. Hear what is possible for developers, makers and marketers. Besides revenue predictions, our new analysis shows recent results, growth rates and market shares.

Our 166 page study gives you 46 tables and 76 charts. See what the future holds for those products and their makers. The following sections explain how our investigation helps.

Predictions for the cardio devices market and its segments - assess sales prospects
What potential does that biomedical industry hold? And what secrets underpin its progress? Discover in our report overall world revenue to 2026 for cardiovascular medical devices.

To see a report overview please email Sara Peerun on sara.peerun@visiongainglobal.com

There you also find individual revenue predictions from 2016 to 2026 at world level for four main submarkets:
• Cardiac rhythm management
• Prosthetic devices
• Interventional cardiology products
• Monitoring and diagnostics.

You also gain world revenue forecasts from 2016 to 2026 for 11 deeper market segments:
• Cardiac pacemakers
• Defibrillators
• Ventricular assist devices
• Coronary stents
• Artificial heart valves
• Catheters
• Angioplasty balloons
• Guidewires
• Accessories
• Electrocardiography products
• Cardiac output monitoring equipment.

That way you assess revenue expansion, seeing where you could gain. You also investigate competition among developers and producers of those cardiac products. Explore marketed brands, emerging technologies and fields with the fastest-rising sales. See what is possible.

Our work also divides its overall world market into geographical revenue predictions.

Sales in leading national markets - what future demand is possible?
Our analyses show you individual revenue forecasts to 2026 for 11 leading countries:
• United States
• Japan
• Germany, France, United Kingdom, Italy and Spain (EU5)
• Brazil, Russia, India and China (BRIC).

You find countries with highest revenues, demand and potential increases in those devices' use. And you understand competitors, users' needs and commercial opportunities. That way you explore trends, progress and potentials, discovering what gains the future holds.

And how do events, challenges and advances in cardiac technology affect that medical device sector? Our study explains.

Forces affecting developers and producers of those cardio products
Our report explains issues, progress and other events affecting that market. Those forces influencing the sector from 2016 include these:
• Incidence and treatment of cardiovascular diseases (CVDs)
• Approval and regulatory systems - explore US FDA and EU regulations
• Effects of US excise tax on medical devices and their sellers
• Expanding market for remote monitoring devices for the blood circulatory system.

And you explore these trends and influences affecting that human healthcare, among other forces:
• Minimally invasive techniques for heart valve replacement, bioabsorbable stents and other product development - assess R&D trends
• Transcatheter aortic valve replacement (TAVR) and other innovations
• Reducing the gap between cardiac devices and MRI scans
• Mergers and acquisitions - explore deals consolidating that medical industry.

With that information in our report you explore progress, trends and advances. You discover what benefits and what restricts participants in that industry, affecting its results.

Prominent companies and 2020 world market value
What does the future hold? Our study predicts that overall market will reach $63.4bn in 2020, more than doubling in revenues from 2015 to 2026. Discover what the future holds.

And our study examines activities of prominent companies:
• Medtronic
• St. Jude Medical
• Boston Scientific
• Biotronik
• Abbott
• Johnson & Johnson
• Edwards Lifesciences
• Terumo
• LivaNova
• CR Bard
• Integer Holdings.

In that work you discover profiles of leading organisations, assessing their activities and potentials. Our new survey explains forces affecting that industry's present and future, revealing trends, opportunities and predictions.

That market gives many opportunities. See where those potential gains lie, discovering how that industry can succeed, benefiting companies, patients and healthcare providers.

Ways Cardiovascular Medical Devices Market and Forecasts 2016-2026 helps your work
In particular our new investigation gives this knowledge to benefit your research, analyses, plans and presentations:
• Revenues for cardio devices, to 2026, at world level and for 15 submarkets - explore prospects for development, production, marketing and investments
• Forecasts, to 2026, for 11 countries in the Americas, Europe and Asia - assess developed and developing national markets for demand and predicted revenues
• Prospects for established firms and rising companies - examine product portfolios, research and development, results, strategies and outlooks
• Analyses of what stimulates and restrains that industry's participants - investigate challenges, strengths and competition affecting organisations' success.

Information found nowhere else, benefiting your insight, work and influence
That study, done in-house by our UK-based analysts, gives independent analysis. There you gain competitive intelligence found only in our report, finding where progress and money lie.

With that data you are less likely to fall behind in information or miss opportunity. See how you could save time and effort. And, through your choice, benefit your plans, decisions and authority, helping you gain competitive advantages.

Data to help your knowledge of products for the human circulatory system - benefit now
Our analysis suits professionals investigating cardio devices for healthcare. With that study you discover trends, results and revenue forecasts. Avoid missing out - instead stay ahead by getting our new report here now.

To see a report overview please email Sara Peerun on sara.peerun@visiongainglobal.com

To request a report overview of this report please emails Sara Peerun at sara.peerun@visiongainglobal.com or call Tel: +44 (0) 20 7336 6100

Or click on https://www.visiongain.com/Report/1733/Cardiovascular-Medical-Devices-Market-and-Forecasts-2016-2026

Organisations Mentioned in the Report 

3M Company

Abbott Laboratories

Agência Nacional de Vigilância Sanitária (ANVISA), Brazil

American Heart Association (AHA)

B. Braun Melsungen AG

Biosense Webster Inc

Biosensors International Group

Biotronik    

Boston Scientific Corporation

CardiAQ Valve Technologies Inc

Cardinal Health Inc

CardioInsight Technologies Inc

Cardiological Society of India (CSI)

CaridianBCT

Center for Devices and Radiological Health (CDRH), US

Central Drug Standard Control Organisation (CDSCO), India

Chinese Food and Drug Administration (CFDA)

Comité Economique des Produits de Santé (CEPS), France

Cordis Corporation

Corventis Inc

Covidien PLC

CR Bard Inc

Cyberonics Inc

Edwards Lifesciences Corporation

EHRA Europace-Cardiostim

European Council

European Heart Rhythm Association (EHRA)

European Society of Cardiology (ESC)

European Union (EU)

Food and Drug Administration (FDA)

French Government

Gemeinsame Bundesausschuss (G-BA)

Government of India (GOI)

Greatbatch Medical

Haute Autorité de santé (HAS), France

Institutional Review Board, US

Integer Holdings Corporation

Italian Government

Johnson & Johnson (J&J)

Kobayashi Pharmaceutical Co Ltd

Lake Region Medical

Livanova PLC

Medicon Inc

Medtronic

Meril Life Sciences Pvt Ltd

MicroVention Inc

Ministry of Health and Family Welfare, India

Ministry of Health, Brazil

Ministry of Health, Labour and Welfare (MHLW), Japan

Ministry of Industry and Trade (Minpromotorg), Russia

Moody's Investors Service

National Heart Institute - US

National Interventional Council (NIC)

NHS Commissioning Board

Preventice Inc

Roszdravnadzor

Servizio Sanitario Nazionale (SSN)

Siemens AG

Silk Road Medical Inc

Sistema Único de Saúde (SUS)

Sorin Group

St Jude Medical Inc

Standard & Poor's Financial Services LLC

Tendyne Holdings Inc

Terumo Corporation

Thoratec Corporation

Twelve Inc

UK Department of Health

United Nations Department of Economic and Social Affairs

US Federal Government

US Patent Office

Vascular Pathways Inc

World Health Organization (WHO)

World Heart Federation

To see a report overview please email Sara Peerun on sara.peerun@visiongainglobal.com

SOURCE Visiongain Ltd